Hypolipid

Quick links to important sections

Hypolipid

Method of action: Lipid Modifying Agents

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hypolipid

Property Description
Active Ingredient Gemfibrozil
Form Oral Tablet
Pharmacological Class Antilipemic Agent (Fibrate)
General Purpose Management of Dyslipidaemia
Origin Synthetic

What Type of Medicine is Hypolipid (Gemfibrozil)?

Hypolipid is a prescription-only synthetic pharmaceutical classified as an antilipemic agent, or lipid-lowering drug, whose active substance is Gemfibrozil. This compound belongs to the chemical class of fibric acid derivatives, commonly known as fibrates. This classification is consistent with pharmaceutical ontologies recognized globally. The medication is administered via the oral route as a tablet and is clinically recognized for its efficacy in improving the lipid profile in adults who have significantly elevated triglycerides.


What is Hypolipid's General Purpose and Composition?

The general therapeutic purpose of Hypolipid is the management of abnormal blood fat profiles, referred to as dyslipidaemia. As a single-ingredient product, it contains the active substance Gemfibrozil within a solid oral vehicle (non-active components). Fibric acid derivatives are effective for achieving therapeutic goals related to high triglyceride levels. This means the medicine is validated as a tool to help control the amount of fatty substances circulating in the bloodstream. The fibric acid derivatives class is effective for addressing these specific lipid abnormalities, particularly when a patient presents with elevated triglycerides alongside low high-density lipoprotein (HDL) cholesterol.


How Does Hypolipid Affect Blood Lipids?

Hypolipid affects lipid metabolism by fundamentally altering how the body handles fats, resulting in a beneficial reduction of serum triglycerides and an attendant increase in HDL cholesterol ("good" cholesterol). Its action is based on functioning as a specific cellular messenger, a PPAR-alpha agonist, which signals the body to adjust fat production. This mechanism is essential to the drug's therapeutic goal of improving the balance of fats within the patient's bloodstream, focusing on optimizing the lipid profile rather than just lowering a single value. This targeted synthetic mechanism offers a specialized approach for patients whose primary concern is triglyceride elevation, a differentiating factor within the broad class of lipid-modifying agents.

What side effects are possible with Hypolipid?

Possible Side Effects and Safety Information: Hypolipid

Hypolipid belongs to the class of medications known as statins, which are generally well-tolerated. However, like all medications, they can cause side effects. Most side effects are mild and often resolve as the body adjusts to the treatment.


Common Side Effects

Commonly reported side effects often involve muscle and digestive issues. These may include:

  • Muscle Aches (Myalgia): Pain, tenderness, or weakness in the muscles. If you experience unexplained muscle pain or weakness, particularly with fever or feeling generally unwell, contact your healthcare provider immediately.
  • Gastrointestinal Issues: Problems such as constipation, diarrhea, indigestion, or abdominal pain.
  • Headache and Dizziness.

Less Common and Serious Side Effects

While rare, some side effects are more serious and require prompt medical attention:

  • Liver Damage: Statins can cause an increase in liver enzyme levels, which is usually detected via blood tests. Severe liver issues are rare. Signs may include unusual fatigue, loss of appetite, upper stomach pain, dark urine, or yellowing of the skin or eyes.
  • Rhabdomyolysis: This is a very rare but severe form of muscle damage that can lead to kidney failure and is life-threatening. The risk increases with higher doses or when taken with certain other medicines.
  • Increased Blood Sugar: Statins have been associated with a small increased risk of developing elevated blood sugar or Type 2 diabetes, especially in those already at risk.
  • Cognitive Effects: Some patients report memory loss or confusion, which typically reverses upon stopping the medication.

Important Safety Information

  • Monitoring: Regular blood tests are necessary to check liver enzyme levels, typically before starting treatment and periodically thereafter.
  • Pregnancy and Breastfeeding: Statins are generally not recommended for use during pregnancy or while breastfeeding.
  • Drug Interactions: Inform your healthcare provider of all other medications and supplements you take, as some can increase the risk of serious side effects, particularly muscle damage. Avoid large quantities of grapefruit juice with some statins, as it can increase the drug level in the blood.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Symptoms and Manifestations

Official regulatory documents describe an overdose of Hypolipid as potentially leading to acute symptoms, signs, and laboratory findings. While clinical data on intentional overexposure may be limited, the official drug information is required to detail known effects based on human or relevant animal studies, which can include accidental intake or dosage errors.

Overdose presentations and subsequent risks are generally related to the pharmacological actions of lipid-lowering agents and may involve serious muscle-related or liver-related effects. These clinical manifestations can sometimes be a severe extension of known adverse effects.

When Immediate Medical Help is Required

It is imperative to seek immediate medical attention if an overdosage is suspected or confirmed. Urgent evaluation is necessary for any high-dose exposure or if concerning symptoms arise.

Symptoms Requiring Urgent Care
Any unexplained or severe muscle pain, tenderness, or weakness.
Symptoms potentially related to liver dysfunction, such as persistent nausea, fatigue, loss of appetite, dark urine, or yellowing of the skin or eyes.
Any signs of systemic illness, particularly if accompanied by fever or malaise.

Management of Overdose

The management of a Hypolipid overdose should follow general supportive measures. There is typically no specific antidote available. Treatment procedures include:**

  • Supportive Care: Maintaining vital signs and continuous monitoring of the patient's condition.
  • Monitoring: Regular assessment of laboratory values, which may focus on the creatine kinase (CK) level to evaluate muscle injury and liver function tests (transaminases) to assess hepatic effects.

The medical team will determine the appropriate clinical course based on the patient's presentation and laboratory findings.

Therapeutic Uses of Hypolipid

Quick Facts on Hypolipid Use

  • Targeted Conditions: High levels of lipids in the blood (hyperlipidemia), including elevated cholesterol and triglycerides.
  • Therapeutic Goal: To assist in the reduction of certain blood lipid levels.
  • Usage Context: Employed as a supplement to dietary measures and lifestyle adjustments.

Hypolipid is a medication used in conjunction with appropriate diet and exercise to manage high levels of certain fats, or lipids, in the bloodstream. The primary therapeutic use of this medication involves supporting the reduction of elevated blood lipid values, such as low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs).

Reducing these levels is a component of a comprehensive approach to address lipid disorders. The medication may be considered for adult patients diagnosed with primary hyperlipidemia, as well as those with significantly high triglyceride values (severe hypertriglyceridemia, defined as 500 mg/dL).

This agent is utilized as an adjunct to modify lipid profiles and contribute to the overall management plan for these conditions.

Eligibility and Restrictions for Use

Who Can and Cannot Use Hypolipid (Gemfibrozil)?

Official regulatory documents define strict criteria for the use of Hypolipid, focusing on patient eligibility and absolute non-eligibility.

Eligibility Scope

Populations for whom use is allowed (as stated in label):

  • Adult patients for specific hyperlipidemia types (e.g., Type IV and V hyperlipidemias).

Populations for whom use is contraindicated:

  • Patients with severe renal dysfunction or hepatic dysfunction (including primary biliary cirrhosis).
  • Individuals with pre-existing gallbladder disease or a history of gallstones.
  • Patients with known hypersensitivity to Gemfibrozil or other fibrates.
  • Patients receiving concomitant therapy with Simvastatin, Repaglinide, or Dasabuvir, among others.

Condition-Specific Restrictions

Age-related eligibility rules: Use in children and adolescents is not established and not recommended due to insufficient data.

Pregnancy and lactation eligibility status: The medicine is generally contraindicated or not recommended during both pregnancy and breastfeeding.

Other limitations: Use requires caution in patients with mild to moderate renal impairment or those with uncontrolled hypothyroidism or diabetes, as these conditions must be managed before starting therapy.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Hypolipid (Gemfibrozil) is based on its documented effects on metabolic enzymes and drug transporters. The co-administration of Hypolipid with certain medicines is formally prohibited due to the risk of serious adverse outcomes. Co-administration is contraindicated with Simvastatin, Repaglinide, Dasabuvir, and Selexipag.


Pharmacokinetic and Pharmacodynamic Interactions

Hypolipid is a documented inhibitor of the CYP2C8 metabolic enzyme and the OATP1B1 transport protein. This dual action increases the systemic exposure and plasma concentrations of co-administered medicines that are substrates for these pathways. This includes an elevated risk of severe muscle toxicity when co-administered with other HMG-CoA Reductase Inhibitors (Statins).

Separately, Hypolipid is documented to potentiate the effects of Coumarin-type Anticoagulants (e.g., Warfarin), requiring close monitoring.


Timing and Substance Constraints

To ensure proper absorption and to prevent reduced exposure, Hypolipid must be taken at least two hours before or two hours after a dose of Bile Acid Sequestrants (e.g., Colestipol). Furthermore, official regulatory information notes that the consumption of alcohol can increase serum triglyceride levels, interfering with the medicine’s therapeutic goal.

Mechanism of Action

How Hypolipid Works


Modulating Lipid Genes via PPARalpha Agonism

The primary mechanism involves the activation of the Peroxisome Proliferator-Activated Receptor alpha ( PPARalpha), a nuclear receptor that acts as a key regulator for fat metabolism. By functioning as an agonist, the compound initiates the transcriptional modulation of specific genes in the liver and muscle. This molecular action controls the synthesis rate of metabolic enzymes and proteins, directly defining the capacity to process triglycerides and HDL components.


Accelerating Systemic Triglyceride Catabolism

This mechanism accelerates the clearance rate of fat from the bloodstream by influencing the VLDL (very-low-density lipoprotein) catabolism pathway. The compound both upregulates Lipoprotein Lipase ( LPL), the enzyme that hydrolyzes triglycerides, and downregulates Apolipoprotein C-III ( ApoC-III), a natural inhibitor of LPL. This combined effect increases the functional rate of the breakdown and clearance of circulating triglyceride-rich particles, leading to the resultant reduction of serum triglycerides.


Influencing the HDL Component Synthesis Pathway

Beyond its effects on triglycerides, the compound modulates the synthesis of high-density lipoprotein ( HDL) components. PPARalpha activation stimulates the increased synthesis of Apolipoprotein A-I ( ApoA-I) and ApoA-II, which are the structural proteins required for building HDL particles. This regulatory step modulates the components of the HDL production pathway, which results in the final physiological effect of increased HDL cholesterol levels.

Dosage and Administration Information

Hypolipid is an oral medication administered strictly according to guidelines that detail its administration route, dosage, and frequency. The standard adult regimen is 1200 mg per day, typically divided into two 600 mg doses. This medication must be taken 30 minutes before both the morning and evening meals, a specific timing intended to optimize drug utilization.

The instructions emphasize that initiating therapy with Gemfibrozil is an adjunctive measure to established lipid-lowering diets and exercise, which must be continued throughout the course of treatment. The duration of use is contingent upon therapeutic response; the medication should be discontinued if a measurable improvement in the patient's lipid profile is not observed after approximately three months of administration.

Dosing regimens require specific adjustments for certain populations. Use in children is not recommended due to insufficient data. For patients with mild to moderate renal impairment, the dose is generally reduced, with some labels recommending a starting dose of 900 mg daily, requiring prior assessment of renal function. In cases where the drug is co-administered with a bile acid sequestrant, the sequestrant must be ingested at least 2 hours before or after the Gemfibrozil dose to prevent interference with absorption.

Recent Clinical Evidence

Hypolipid: Recent Clinical Evidence

Research has explored whether Hypolipid affects symptoms associated with [Condition Name]. Clinical trials focusing on the single-agent use of Hypolipid were conducted across several sites involving adult participants diagnosed with [Condition Name].


Key Findings from Monotherapy Studies

  • Symptom Effects: Studies evaluated whether Hypolipid was assessed for its potential to affect symptoms. Research examined effects on measures of joint function. Investigators also explored the onset of action and documentation of early symptom relief.
  • Outcomes: Study findings were documented across the participant group. Specifically, research examined long-term measurements related to reported pain in a Phase 3 trial over 52 weeks.
  • Safety Profile: Researchers assessed tolerability and the safety profile in adult participants.

Studies on Combination Therapy

A separate set of investigations focused on the administration of Hypolipid alongside [Second Drug Name] in individuals with advanced [Condition Name].

Comparative and Long-term Research

  • Efficacy Comparisons: One large-scale study compared its effects to a placebo group and a group receiving [Other Treatment]. The study's aim was to evaluate any differences in symptom progression across the groups.
  • Risk Evaluation: Research examined whether it influenced the occurrence of secondary complications associated with [Condition Name].
  • Inflammatory Markers: Research assessed the impact of the combination on systemic inflammatory markers, noting a corresponding measurement change.

Summary of Evidence

The available evidence explores the profile of Hypolipid as a monotherapy and in combination. Overall, the findings were mixed across various endpoints, and evidence remains limited regarding definitive, long-term therapeutic outcomes. Due to the variability in study designs and populations, it is not yet clear whether the observed effects are consistent across all patient subgroups.

Key Studies & References

  1. Pharmacokinetics, Mechanism of Action, and Tolerability of Hypolipid in Healthy Adult Volunteers: A Phase 1 Study

Frequently Asked Questions (FAQ)

Common questions about Hypolipid (FAQ)


Q: Why did my doctor prescribe Hypolipid instead of Lipitor or Crestor?

A: Hypolipid (Gemfibrozil) is a type of lipid-lowering drug called a fibrate. Official information states it is primarily used to significantly reduce high triglycerides and raise HDL cholesterol. This is a different focus from statin medications like Lipitor or Crestor, which are generally prescribed to target and lower LDL cholesterol (often called 'bad' cholesterol).

Q: Is it true that Hypolipid can help lower triglycerides as well as LDL cholesterol?

A: Yes, official regulatory documents state that Hypolipid is indicated for the reduction of significantly elevated triglycerides and to increase HDL cholesterol. While its strongest effect is on triglycerides, it is also indicated to reduce total cholesterol and LDL cholesterol in patients being treated for specific types of lipid disorders.

Q: Can Hypolipid affect my memory or make me feel foggy?

A: In some post-marketing reports for this class of medications, some patients have reported experiencing cognitive effects such as confusion or memory loss. Additionally, official information notes that dizziness or lightheadedness may occur as a less common side effect. Concerns about mental clarity or cognitive effects should be discussed with a healthcare provider.

Q: Are there any foods I should avoid eating when taking Hypolipid?

A: Regulatory information advises patients to avoid consuming large amounts of alcohol while taking this medication. Hypolipid treatment is also intended to be used along with a complete program that includes a diet restricted in saturated fat and cholesterol. The diet is intended to be followed closely as part of the treatment program.

Q: Do I still need to diet and exercise if I'm taking Hypolipid?

A: Yes. According to official product information, taking Hypolipid medication is recommended as an adjunct (an addition) to non-pharmacological measures, such as established diet and exercise programs. These lifestyle measures are intended to be continued throughout the course of treatment, as they are a core component of the drug's approved use.

Q: What is the typical starting dosage for Hypolipid, generally speaking?

A: Official regulatory documents define the usual recommended adult dose for this medication. The recommended regimen involves taking the medication twice daily, with specific timing relative to meals.

Q: Does taking Hypolipid increase the risk of developing diabetes?

A: Regulatory documents for drugs in the same class have noted a small association with increases in measures of blood sugar. Patients should expect their blood sugar status to be monitored by a healthcare provider.

Q: Why do doctors often combine Hypolipid with a statin for some patients?

A: The official product information lists that Hypolipid is contraindicated (should not be used) with certain statin medications, such as Simvastatin, due to a severe risk of muscle toxicity. Combination therapy is a clinical decision that is made only when the potential benefits are determined to outweigh the serious risks.

Q: How does Hypolipid affect my 'good' HDL cholesterol levels?

A: One of the key effects of Hypolipid is to increase the levels of HDL cholesterol in your blood. HDL cholesterol is often called 'good' cholesterol because it helps remove excess cholesterol from the bloodstream.

Q: What conditions besides high cholesterol is Hypolipid sometimes used for?

A: Official regulatory information indicates that Hypolipid is used to help reduce the risk of coronary heart disease (CHD) mortality in specific adult patients. This applies to individuals with particular lipid profiles who have not responded adequately to diet and other non-drug measures alone.

Q: Does taking Hypolipid cause muscle aches or joint pain?

A: Muscle pain, tenderness, or weakness (myalgia) is listed in the official documents as a possible side effect. Joint pain (arthralgia) is also reported in some adverse reaction data. The occurrence of unexplained muscle pain, especially if accompanied by fever or feeling unwell, should be promptly reported to a healthcare provider.

Q: Is there a risk of liver problems associated with taking Hypolipid long-term?

A: Official information notes that abnormal liver function tests have been observed occasionally, which typically return to normal upon stopping the medication. Hypolipid is contraindicated in patients who already have liver dysfunction, and long-term monitoring of liver function is recommended while taking the drug.

Q: Does Hypolipid have a generic equivalent, and what is it called?

A: The active ingredient in Hypolipid is Gemfibrozil. This is the generic name for the medication.

Q: How long do most people need to stay on Hypolipid?

A: The duration of treatment is based on your therapeutic response. Regulatory information states that if a measurable improvement in your lipid profile is not seen after approximately three months of therapy, the medication should be discontinued.

Q: Why is it important to check my liver function while on Hypolipid?

A: It is important because periodic liver function tests are recommended. This is a safety measure, as official information indicates that occasional increases in liver enzyme levels, which may signal a problem, have been observed.

Q: Is Hypolipid typically taken with food or on an empty stomach?

A: The official administration instructions state that Hypolipid is usually taken orally twice a day, specifically 30 minutes before the morning and evening meals.

Q: What is the longest continuous time people have been studied taking Hypolipid?

A: Major clinical studies involving this medication have followed patients for up to five years to thoroughly assess its effects, particularly on reducing the risk of coronary heart disease events over time.

Q: What percentage of people experience the more severe side effects of Hypolipid?

A: Official information generally classifies severe side effects as 'rare' or 'less common.' Incidence data for severe events are typically detailed in the official Prescribing Information.

Q: Can Hypolipid cause insomnia or disrupt my sleep patterns?

A: While regulatory documents do not specifically list insomnia, the medication has been associated with somnolence (drowsiness) in some adverse event reports. Any significant changes to sleep patterns should be discussed with a healthcare provider.

Q: What is the recommended storage temperature for Hypolipid tablets?

A: Official instructions state that Hypolipid tablets should be stored at controlled room temperature. This is necessary to maintain the drug’s stability and effectiveness. They must also be kept away from excess light and moisture.

Q: Why do some people refer to Hypolipid as a cholesterol 'absorption inhibitor'?

A: Hypolipid (Gemfibrozil) belongs to the fibrate class of drugs. It primarily works inside the body by activating a nuclear receptor ( PPARalpha) that changes how your body breaks down and produces fat. Cholesterol absorption inhibitors are a separate class of lipid-lowering drugs that block cholesterol uptake in the gut.

Q: How does Hypolipid affect the level of VLDL cholesterol?

A: Hypolipid works by increasing the catabolism (breakdown) of VLDL (very-low-density lipoprotein) particles. This action is crucial to its therapeutic goal, as VLDL particles carry a large amount of triglycerides, leading to a reduction in serum triglyceride levels.

Q: What information is available regarding Hypolipid's long-term safety profile?

A: Long-term studies have been conducted to assess the chronic safety profile. Official documents advise that due to the chronic nature of lipid disorders, continuous long-term monitoring is necessary, including periodic checks of blood counts and liver function.

Q: Why is it important not to abruptly stop taking Hypolipid?

A: This medication is used to manage high triglycerides and low HDL, which are chronic conditions. Patients should continue taking the medication as directed by their prescription and should not discontinue it without first consulting a healthcare provider.

Q: Are there different brand names for the same medication as Hypolipid?

A: Yes, Gemfibrozil (the active ingredient in Hypolipid) is available under other brand names. The most common brand name for Gemfibrozil in the U.S. is Lopid.

Q: Can people with diabetes safely take Hypolipid?

A: Official information states that use requires caution in patients with diabetes, as the underlying condition must be well-managed before starting therapy. Patients with diabetes may also face a higher risk of certain adverse events, like muscle problems, when taking drugs of this class.

Q: Is Hypolipid safe for older adults over 65?

A: Official information indicates that studies did not include enough patients over the age of 65 to fully determine if their response is different from younger patients. Older adults may require cautious dosing, reflecting the greater frequency of decreased renal function in this population.

Q: How often do I need blood tests while taking Hypolipid?

A: Periodic blood tests are recommended to monitor your liver function and blood cell counts. This is particularly important during the first 12 months of administration.

Q: What is the difference in how Hypolipid works compared to common statins?

A: Hypolipid (a fibrate) activates a nuclear receptor ( PPARalpha) to influence the way your body breaks down fat and helps to increase HDL cholesterol. In contrast, common statins primarily work by inhibiting a specific liver enzyme ( HMG-CoA reductase) to reduce the liver's production of cholesterol.

Q: Is Hypolipid a daily medication, or is it taken less frequently?

A: The standard regimen involves taking the medication twice daily.

Q: Are there any specific dietary fats I should avoid completely while on Hypolipid?

A: Hypolipid is intended to be used along with a diet that is specifically restricted in saturated fat and cholesterol. Adhering to this prescribed diet is considered a core part of the overall treatment plan.

Q: Can people with kidney issues take Hypolipid safely?

A: The official label contraindicates (prohibits) the use of Hypolipid in patients with severe renal dysfunction. Use in patients with mild to moderate kidney impairment requires caution and careful monitoring of their renal function.

Q: What are the signs of a serious, but rare, side effect from Hypolipid?

A: Serious side effects, though rare, can include signs of severe muscle damage ( Rhabdomyolysis), which may appear as unexplained muscle pain, weakness, or tenderness, especially with fever. Signs of severe liver issues can include yellowing of the skin or eyes ( jaundice) or unusual abdominal pain.

Q: Can taking Hypolipid cause dizziness or lightheadedness?

A: Official regulatory documents list dizziness as a common side effect of Hypolipid. Additionally, lightheadedness is mentioned in connection with certain serious, but rare, adverse reactions affecting blood cells.

Q: Are there any groups of people for whom Hypolipid is less effective?

A: Regulatory documents state that clinical trials focused on the drug's approved indications. Efficacy in other groups, such as specific racial populations, is not fully established or detailed in the official product information.

Q: Do lifestyle changes make Hypolipid more effective?

A: The official product information specifies that Hypolipid is meant to be used as an adjunct (addition) to a continuous, established diet and exercise regimen. Continuing these lifestyle changes is a required part of the treatment program and is considered essential to achieving the drug’s therapeutic goals.

How should Hypolipid be stored and disposed of?

How to Store and Dispose of Hypolipid (Gemfibrozil) Tablets

The storage and disposal of Hypolipid tablets must strictly adhere to conditions specified in official regulatory documents to maintain product integrity and household safety.

Storage Requirements

Hypolipid tablets must be kept at room temperature, generally below 25 C, and kept from freezing. Storage must be away from excess heat, light, and moisture. To maintain stability, the medication should remain in its original, tightly closed container.

Handling and Disposal

A critical safety requirement is to keep the medication out of the sight and reach of children.

Unused or expired Hypolipid must be disposed of in accordance with local regulatory requirements. Official documentation indicates no special requirements for disposal, meaning it is not classified as a hazardous waste product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hypolipid found in:

A-Z Index: